4GPI

Crystal structure of human B type phosphoglycerate mutase


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.08 Å
  • R-Value Free: 0.233 
  • R-Value Work: 0.190 
  • R-Value Observed: 0.192 

wwPDB Validation 3D Report Full Report



Literature

Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.

Hitosugi, T.Zhou, L.Fan, J.Elf, S.Zhang, L.Xie, J.Wang, Y.Gu, T.L.Aleckovic, M.Leroy, G.Kang, Y.Kang, H.B.Seo, J.H.Shan, C.Jin, P.Gong, W.Lonial, S.Arellano, M.L.Khoury, H.J.Chen, G.Z.Shin, D.M.Khuri, F.R.Boggon, T.J.Kang, S.He, C.Chen, J.

(2013) Nat Commun 4: 1790-1790

  • DOI: 10.1038/ncomms2759
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • How oncogenic signalling coordinates glycolysis and anabolic biosynthesis in cancer cells remains unclear. We recently reported that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1) regulates anabolic biosynthesis by controlling intracellular ...

    How oncogenic signalling coordinates glycolysis and anabolic biosynthesis in cancer cells remains unclear. We recently reported that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1) regulates anabolic biosynthesis by controlling intracellular levels of its substrate 3-phosphoglycerate and product 2-phosphoglycerate. Here we report a novel mechanism in which Y26 phosphorylation enhances PGAM1 activation through release of inhibitory E19 that blocks the active site, stabilising cofactor 2,3-bisphosphoglycerate binding and H11 phosphorylation. We also report the crystal structure of H11-phosphorylated PGAM1 and find that phospho-H11 activates PGAM1 at least in part by promoting substrate 3-phosphoglycerate binding. Moreover, Y26 phosphorylation of PGAM1 is common in human cancer cells and contributes to regulation of 3-phosphoglycerate and 2-phosphoglycerate levels, promoting cancer cell proliferation and tumour growth. As PGAM1 is a negative transcriptional target of TP53, and is therefore commonly upregulated in human cancers, these findings suggest that Y26 phosphorylation represents an additional acute mechanism underlying phosphoglycerate mutase 1 upregulation.


    Organizational Affiliation

    Department of Haematology and Medical Oncology, Winship Cancer Institute of Emory, Emory University School of Medicine, Atlanta, Georgia 30322, USA.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Phosphoglycerate mutase 1B, C262Homo sapiensMutation(s): 0 
Gene Names: PGAM1PGAMACDABP0006
EC: 3.1.3.13 (PDB Primary Data), 5.4.2.1 (PDB Primary Data), 5.4.2.4 (PDB Primary Data), 5.4.2.11 (UniProt)
Find proteins for P18669 (Homo sapiens)
Explore P18669 
Go to UniProtKB:  P18669
NIH Common Fund Data Resources
PHAROS  P18669
Protein Feature View
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
CL
Query on CL

Download CCD File 
B
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.08 Å
  • R-Value Free: 0.233 
  • R-Value Work: 0.190 
  • R-Value Observed: 0.192 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 81.662α = 90
b = 80.263β = 90
c = 89.275γ = 90
Software Package:
Software NamePurpose
HKL-2000data collection
PHASESphasing
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2012-08-21 
  • Released Date: 2013-05-22 
  • Deposition Author(s): Zhou, L., He, C.

Revision History 

  • Version 1.0: 2013-05-22
    Type: Initial release